Similar articles

• Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women.

  Clearfield M. Clearfield M. Curr Atheroscler Rep. 2006 Jan;8(1):10-2. Curr Atheroscler Rep. 2006. PMID: 16455008 No abstract available.
• Treating average cholesterol levels in patients with coronary heart disease.

  Lindbloom EJ. Lindbloom EJ. J Fam Pract. 1999 Feb;48(2):94-5. J Fam Pract. 1999. PMID: 10037537 No abstract available.
• Hypercholesterolemia: a reversible risk factor for coronary heart disease.

  Mishkel MA. Mishkel MA. CMAJ. 1989 Feb 15;140(4):419. CMAJ. 1989. PMID: 2644008 Free PMC article. Clinical Trial. No abstract available.
• Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.

  Marchioli R, Marfisi RM, Carinci F, Tognoni G. Marchioli R, et al. Arch Intern Med. 1996 Jun 10;156(11):1158-72. Arch Intern Med. 1996. PMID: 8639010 Review.
• Cholesterol: myth or reality?

  Thompson WG. Thompson WG. South Med J. 1990 Apr;83(4):435-40. South Med J. 1990. PMID: 2181692 Review. No abstract available.